DEVELOPMENT AND CLINICAL VALIDATION OF A REAGENT KIT FOR SIMULTANEOUS DETECTION OF INFLUENZA A, B, INFLUENZA A H1pdm09 AND CORONAVIRUS SARS-CoV-2

DOI: https://doi.org/10.29296/25877305-2023-04-17
Issue: 
4
Year: 
2023

M. Dmitryukova(1), Candidate of Biological Sciences; M. Maltyzova(1),M. Senina(1),A. Gushin(2, 3), Candidate of Biological Sciences
1-NextBio LLC, Moscow
2-Moscow Research and Practical Center for Dermatovenereology
and Cosmetology, Moscow Healthcare Department
3I-nterLabService LLC, Moscow

Respiratory tract infections are the main cause of temporary disability for work and take a major toll on economies in whole world. Early and accurate detection of etiological agent will improve treatment efficiency and prevent spreading of epidemy. The reagent kit for simultaneous detection of influenza A, B virus, H1pdm09 influenza A strain and coronavirus SARS-CoV-2 was developed. For clinical validation TIB Molbiol (E gene) kit (for detection of SARS-CoV-2) and CDC Influenza Virus Real-Time RT-PCR Panel Influenza A/B typing Panel were used. The assay has shown high sensitivity and specificity against different strains of SARS-CoV-2 and influenza viruses. The analytical sensitivity was 500 copies/ml for detection of Influenza A and B viruses and 250 copies/ml for SARS-CoV-2. No cross-reaction with other respiratory pathogens was detected. Clinical sensitivity and specificity against comparator test were 100%. Developed reagent kit intended for use in clinical laboratories for differentiating diagnosis of coronaviral infection and influenza A and B.
Keywords: 
validation
polymerase chain reaction
SARS-CoV-2
influenza

References: 
  1. Отчет о текущей ситуации по борьбе с коронавирусом, 30 июня 2022. Коммуникационный центр правительства Российской Федерации [Report on current situation of COVID-19 control and prevention, Communication center of Russian Federation government. 30 July 2022 (in Russ.)]. URL: https://cdn.stopcoronovirus.ru/ai/doc/1442/attach/2022-06-30_coronavirus_government_ report.pdf
  2. Sallard E., Halloy J., Casane D. et al. Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review. Environ Chem Lett. 2021; 19 (2): 769–85. DOI: 10.1007/s10311-020-01151-1
  3. Smith G.J., Vijaykrishna D., Bahl J. et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459 (7250): 1122–5. DOI: 10.1038/nature08182
  4. Everett H.E., Nash B., Londt B.Z. et al. Interspecies Transmission of Reassortant Swine Influenza A Virus Containing Genes from Swine Influenza A(H1N1)pdm09 and A(H1N2) Viruses. Emerg Infect Dis. 2020; 26 (2): 273–81. DOI: 10.3201/eid2602.190486
  5. Еженедельный национальный бюллетень по гриппу и ОРВИ за 52 неделю 2021 г. (27.12.21–02.01.22) [National weekly influenza bulletin of the Russian Federation, week 52 of 2021 (27.12.21–02.01.22) (in Russ.)]. URL: https://www.influenza.spb.ru/system/epidemic_situation/laboratory_diagnostics/?year=2021&week=52
  6. Kim E.H., Nguyen T.Q., Casel M.A.B. et al. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4+ T Cell Responses. J Virol. 2022; 96 (6): e0187321. DOI: 10.1128/jvi.01873-21
  7. Swets M., Russell C.D., Harrison EM. et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022; 399 (10334): 1463–4. DOI: 10.1016/S0140-6736(22)00383-X
  8. Aggarwal N., Potdar V., Vijay N. et al. SARS-CoV-2 and Influenza Virus Co-Infection Cases Identified through ILI/SARI Sentinel Surveillance: A Pan-India Report. Viruses. 2022; 14 (3): 627. DOI: 10.3390/v14030627
  9. Corman V.M., Landt O., Kaiser M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25 (3): 2000045. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045
  10. Shu B., Kirby M.K., Davis W.G. et al. Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2021; 27 (7): 1821–30. DOI: 10.3201/eid2707.210462
  11. US Food and Drug Administration. 510 (k): CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel. 2020 [2020 Mar 10]. URL: https://www.accessdata.fda.gov/cdrh_docs/pdf20/K200370.pdf
  12. Красько О.В. Статистический анализ данных в медицинских исследованиях: в 2 ч. Ч. I. Минск: МГЭУ им. А.Д. Сахарова, 2014; 127 с. [Kras’ko О.V. Statistical data analysis in medical studies: in 2 vol. Vol. I Minsk: MGEU im. A.D. Sakharova, 2014; p. 127 (in Russ.)].
  13. Yip C.C., Sridhar S., Cheng A.K. et al. Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection. J Clin Virol. 2020; 129: 104476. DOI: 10.1016/j.jcv.2020.104476
  14. Abdelrahman Z., Li M., Wang X. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. Front Immunol. 2020; 11 (11): 552909. DOI: 10.3389/fimmu.2020.552909
  15. Barra G.B., Santa Rita T.H., Mesquita P.G. et al. Analytical Sensitivity and Specificity of Two RT-qPCR Protocols for SARS-CoV-2 Detection Performed in an Automated Workflow. Genes. 2020; 11 (10): 1183. DOI: 10.3390/genes11101183
  16. Mizoguchi M., Harada S., Okamoto K. et al. Comparative performance and cycle threshold values of 10 nucleic acid amplification tests for SARS-CoV-2 on clinical samples. PLoS One. 2021; 16 (6): e0252757. DOI: 10.1371/journal.pone.0252757
  17. Bruce E.A., Mills M.G., Sampoleo R. et al. Predicting infectivity: comparing four PCR-based assays to detect culturable SARS-CoV-2 in clinical samples. EMBO Mol Med. 2022; 14 (2): e15290. DOI: 10.15252/emmm.202115290
  18. Platten M., Hoffmann D., Grosser R. et al. SARS-CoV-2, CT-Values, and Infectivity – Conclusions to Be Drawn from Side Observations. Viruses. 2021; 13 (8): 1459. DOI: 10.3390/ v13081459.
  19. Жирнов О.П. Асимметричная структура вируса гриппа А и новая функция матриксного белка М1. Вопросы вирусологии. 2016; 61 (4): 149–54 [Zirnov O.P. Asymmetrical structure of the Influenza A virus and novel function of the matrix protein M1. Problems of Virology. 2016; 61 (4): 149–54 (in Russ.)]. DOI: 10.18821/0507-4088-2016-61-4-149-154
  20. Baldo V., Bertoncello C., Cocchio S. et al. The new pandemic influenza A/(H1N1)pdm09 virus: is it really "new"? J Prev Med Hyg. 2016; 57 (1): E19–22.